Nonetheless, our findings suggest that the SKP2–FOXA1 interplay is a better prognosis factor for PCa and merits further investigation into promoting a more luminal‐like identity which may enhance therapeutic sensitivity to abrogate FOXA1‐driven PCa. This evidence concerns the gene FOXA1 and posterior cortical atrophy.